Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why Investors Are Buzzing about These Five Stocks

All three major indexes are in the green this morning despite the ADP reporting that private payrolls in the U.S. rose by 154,000 for the month of September, versus the Street estimate of 165,000. WTI futures nearing $50 per barrel on a solid API report yesterday could be one reason for the relative strength.

In this article, we will take a closer look at five stocks traders are buzzing about, Monsanto Company (NYSE:MON), RPM International Inc. (NYSE:RPM), Acuity Brands, Inc. (NYSE:AYI), AZZ Inc (NYSE:AZZ), and Netflix, Inc. (NASDAQ:NFLX). We will also see how the smart money was positioned towards each stock.

Through extensive research, we determined that imitating some of the picks of hedge funds and other institutional investors can help generate market-beating returns over the long run. The key is to focus on the small-cap picks of these investors, since they are usually less followed by the broader market and are less price-efficient. Our backtests that covered the period between 1999 and 2012, showed that following the 15 most popular small-caps among hedge funds can help a retail investor beat the market by an average of 95 basis points per month (see the details here).

Netflix, Inc. (NASDAQ:NFLX), homepage, streaming, Ipad, video, tv, tablet, app, watch,

Twin Design /

Monsanto Company (NYSE:MON) is in the spotlight after the company reported fiscal fourth-quarter earnings of $0.07 per share on revenue of $2.56 billion, beating the consensus estimates by $0.09 and $320 million, respectively. Sales advanced by 8.5% year-over-year, helped by higher volumes in the corn seed division. For full fiscal 2017, Monsanto Company expects EPS between $4.50 and $4.90 per share. Although that’s lower than the Street estimate of $4.92 per share, shares of the company are relatively unchanged. Monsanto agreed to sell itself to Bayer for $128 per share in cash in a deal that should close by the end of next year (if approved by regulators). Dan Loeb‘s Third Point established a new stake of 2 million shares in Monsanto Company (NYSE:MON) during the second quarter.

Follow Monsanto Co W (NYSE:MON)
Trade (NYSE:MON) Now!

RPM International Inc. (NYSE:RPM) earned $0.83 per share in its fiscal first quarter, beating the estimates by $0.02 per share. Revenue came in at $1.25 billion, up by 0.8% year-over-year, and $20 million below the Street’s consensus estimate. Revenues fell short of expectations mainly due to the strong dollar, the weak energy market, and the soft global macro-economy.  In terms of guidance, RSM International’s management continues to expect full fiscal 2017 diluted EPS between $2.68 and $2.78. The number of funds from our database with holdings in RPM International Inc. (NYSE:RPM) fell by one quarter-over-quarter to 21 at the end of June.

Follow Rpm International Inc (NYSE:RPM)
Trade (NYSE:RPM) Now!

On the next page, we examine Acuity Brands, AZZ, and Netflix.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.